Glycyrrhizin and glycyrrhetinic acid directly modulate rat cardiac performance

Journal of Nutritional Biochemistry

Volumn 23, Issue 1, 2012, Pages 69-75

  Parisella, Maria L ^a   Angelone, Tommaso ^a   Gattuso, Alfonsina ^a   Cerra, Maria C ^a   Pellegrino, Daniela ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Endothelin 1; Glycyrrhetinic acid; Glycyrrhizin; Myocardial contractility; Nitric oxide

Indexed keywords

ENDOTHELIN RECEPTOR; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY PRESSURE; DRUG EFFECT; HEART CONTRACTION; HEART MUSCLE RELAXATION; HEART PERFORMANCE; HEART PERFUSION; HEART RATE; INOTROPISM; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; HEART; HEART RATE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PERFUSION; RATS; RECEPTOR, ENDOTHELIN A; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES;

RATTUS;

EID: 83355172179     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.10.011     Document Type: Article

References (22)

1. Armanini D., Fiore C., Mattarello M.J., Bielenberg J., Palermo M. History of the endocrine effects of licorice. Exp Clin Endocrinol Diabetes 2002, 110:257-261.
2. Fiore C., Eisenhut M., Ragazzi E., Zanchin G., Armanini D. A history of the therapeutic use of liquorice in Europe. J Ethnopharmacol 2005, 99:317-324.
3. Asl M.N., Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 2008, 22:709-724.
4. Aly A.M., Al-Alousi L., Salem H.A. Licorice: a possible anti-inflammatory and anti-ulcer drug. AAPS Pharm Sci Tech 2005, 6:E74-82.
5. Lee J.R., Park S.J., Lee H.S., Jee S.Y., Seo J., Kwon Y.K., et al. Hepatoprotective activity of licorice water extract against cadmium-induced toxicity in rats. Evid Based Complement Alternat Med 2009, 6:195-201.
6. Fiore C., Eisenhut M., Krausse R., Ragazzi E., Pellati D., Armanini D., et al. Antiviral effects of Glycyrrhiza species. Phytother Res 2008, 22:141-148.
7. Hibasami H., Iwase H., Yoshioka K., Takahashi H. Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells. Int J Mol Med 2005, 16:233-236.
8. Battaglia V., Brunati A.M., Fiore C., Rossi C.A., Salvi M., Tibaldi E., et al. Glycyrrhetinic acid as inhibitor or amplifier of permeability transition in rat heart mitochondria. Biochim Biophys Acta 2008, 1778:313-323.
9. Kilgore K.S., Tanhehco E.J., Park J.L., Naylor K.B., Anderson M.B., Lucchesi B.R. Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics. J Pharmacol Exp Ther 1998, 284:427-435.
10. Ploeger B., Mensinga T., Sips A., Seinen W., Meulenbelt J., DeJongh J. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Drug Metab Rev 2001, 33:125-147.
11. Ruschitzka F., Quaschning T., Noll G., deGottardi A., Rossier M.F., Enseleit F., et al. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide. Circulation 2001, 103:3129-3135.
12. Rodríguez-Sinovas A., García-Dorado D., Ruiz-Meana M., Soler-Soler J. Protective effect of gap junction uncouplers given during hypoxia against reoxygenation injury in isolated rat hearts. Am J Physiol Heart Circ Physiol 2006, 290:H648-H656.
13. Goubaeva F., Mikami M., Giardina S., Ding B., Abe J., Yang J. Cardiac mitochondrial connexin 43 regulates apoptosis. Biochem Biophys Res Commun 2007, 352:97-103.
14. Angelone T., Quintieri A.M., Brar B.K., Limchaiyawat P.T., Tota B., Mahata S.K., et al. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology 2008, 149:4780-4793.
15. Brunner F., Brás-Silva C., Cerdeira A.S., Leite-Moreira A.F. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 2006, 111:508-531.
16. De Artinano A.A., Gonzalez V.L. Endothelial dysfunction and hypertensive vasoconstriction. Pharmacol Res 1999, 40:113-124.
17. Shome K., Rizzo M.A., Vasudevan C., Andresen B., Romero G. The activation of phospholipase D by endothelin-1, angiotensin II, and platelet-derived growth factor in vascular smooth muscle A10 cells is mediated by small G proteins of the ADP-ribosylation factor family. Endocrinology 2000, 141:2200-2208.
18. Marrero M.B., Venema V.J., Ju H., He H., Liang H., Caldwell R.B., et al. Endothelial nitric oxide synthase interactions with G-protein-coupled receptors. Biochem J 1999, 343:335-340.
19. Herrera M., Garvin J. Endothelin stimulates endothelial nitric oxide synthase expression in the thick ascending limb. Am J Physiol Renal Physiol 2004, 287:F231-F235.
20. Spinella F., Garrafa E., Di Castro V., Rosanò L., Nicotra M.R., Caruso A., et al. Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade. Cancer Res 2009, 69:2669-2676.
21. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399:597-601.
22. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605.